|
News Releases
 Vital Therapies Announces Presentation of ELAD® “Artificial Liver” Data at American Association for the Study of Liver Diseases 2007 Annual Meeting
Vital Therapies Closes $28.1 Million Financing
The Rush To Test Drugs In China - Business Week
Vital Therapies Appoints Liver Transplant Expert to Board of Directors
ELAD® Bioartificial Liver Trial in China Achieves Significance at Halfway Point
Vital Therapies Receives FDA Guidance Allowing for the Shipment of ELAD Liver Assist System Cartridges to China
Vital Therapies Completes First Closing of $8 Million Private Equity Financing
Vital
Therapies, Inc. Receives Orphan Drug Designation for
Key Component in Liver
Assist Program
Massachusetts
General Hospital Patient Saved by ELAD®
Documents
Links
Health
and Human Services
Organ Procurement
Network
United
Network for Organ Sharing
American
Liver Foundation
National
Institutes of Health
American
Association for the Study of Liver Diseases
|
